T32 CA060441/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2007	2
2008	2
2009	5
2010	3
2011	3
2012	2
2013	6
2014	5
2015	4
2016	8
2017	2
2018	5
2019	4
2020	7
2021	6
2022	6
2023	6
2024	4

1

Hsu AP, McReynolds LJ, Holland SM. Hsu AP, et al. Curr Opin Allergy Clin Immunol. 2015 Feb;15(1):104-9. doi: 10.1097/ACI.0000000000000126. Curr Opin Allergy Clin Immunol. 2015. PMID: 25397911 Free PMC article. Review.

2

Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma.

Odeniyide P, Yohe ME, Pollard K, Vaseva AV, Calizo A, Zhang L, Rodriguez FJ, Gross JM, Allen AN, Wan X, Somwar R, Schreck KC, Kessler L, Wang J, Pratilas CA. Odeniyide P, et al. Oncogene. 2022 May;41(21):2973-2983. doi: 10.1038/s41388-022-02305-x. Epub 2022 Apr 22. Oncogene. 2022. PMID: 35459782 Free PMC article.

3

Alternative immune effector cells picking up speed.

Weber E, Bleakley M, Cronk JC, Shah NN, Perna F. Weber E, et al. Mol Ther. 2024 Mar 6;32(3):563-564. doi: 10.1016/j.ymthe.2024.01.030. Epub 2024 Feb 9. Mol Ther. 2024. PMID: 38340733 No abstract available.

4

The impact of epigenetic modifications on allogeneic hematopoietic stem cell transplantation.

Ktena YP, Dionysiou M, Gondek LP, Cooke KR. Ktena YP, et al. Front Immunol. 2023 May 31;14:1188853. doi: 10.3389/fimmu.2023.1188853. eCollection 2023. Front Immunol. 2023. PMID: 37325668 Free PMC article. Review.

5

Gene-Based Natural Killer Cell Therapies for the Treatment of Pediatric Hematologic Malignancies.

Rahnama R, Christodoulou I, Bonifant CL. Rahnama R, et al. Hematol Oncol Clin North Am. 2022 Aug;36(4):745-768. doi: 10.1016/j.hoc.2022.03.007. Epub 2022 Jun 27. Hematol Oncol Clin North Am. 2022. PMID: 35773048 Free PMC article. Review.

6

Epigenetic modulators, modifiers and mediators in cancer aetiology and progression.

Feinberg AP, Koldobskiy MA, Göndör A. Feinberg AP, et al. Nat Rev Genet. 2016 May;17(5):284-99. doi: 10.1038/nrg.2016.13. Epub 2016 Mar 14. Nat Rev Genet. 2016. PMID: 26972587 Free PMC article. Review.

7

Human multipotent adult progenitor cells effectively reduce graft-vs-host disease while preserving graft-vs-leukemia activity.

Metheny L, Eid S, Wuttisarnwattana P, Auletta JJ, Liu C, Van Dervort A, Paez C, Lee Z, Wilson D, Lazarus HM, Deans R, Vant Hof W, Ktena Y, Cooke KR. Metheny L, et al. Stem Cells. 2021 Nov;39(11):1506-1519. doi: 10.1002/stem.3434. Epub 2021 Jul 28. Stem Cells. 2021. PMID: 34255899 Free PMC article.

8

Clonality and evolutionary history of rhabdomyosarcoma.

Chen L, Shern JF, Wei JS, Yohe ME, Song YK, Hurd L, Liao H, Catchpoole D, Skapek SX, Barr FG, Hawkins DS, Khan J. Chen L, et al. PLoS Genet. 2015 Mar 13;11(3):e1005075. doi: 10.1371/journal.pgen.1005075. eCollection 2015 Mar. PLoS Genet. 2015. PMID: 25768946 Free PMC article.

9

The bone marrow microenvironment and leukemia: biology and therapeutic targeting.

Sison EA, Brown P. Sison EA, et al. Expert Rev Hematol. 2011 Jun;4(3):271-83. doi: 10.1586/ehm.11.30. Expert Rev Hematol. 2011. PMID: 21668393 Free PMC article. Review.

10

Defibrotide modulates pulmonary endothelial cell activation and protects against lung inflammation in pre-clinical models of LPS-induced lung injury and idiopathic pneumonia syndrome.

Klein OR, Ktena YP, Pierce E, Fu HH, Haile A, Liu C, Cooke KR. Klein OR, et al. Front Immunol. 2023 Jun 27;14:1186422. doi: 10.3389/fimmu.2023.1186422. eCollection 2023. Front Immunol. 2023. PMID: 37441074 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

70 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year